picibanil and Hemolytic-Uremic-Syndrome

picibanil has been researched along with Hemolytic-Uremic-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for picibanil and Hemolytic-Uremic-Syndrome

ArticleYear
[A case report of hemolytic uremic syndrome (HUS) induced by antineoplastic agents].
    Nihon Gan Chiryo Gakkai shi, 1990, Jul-20, Volume: 25, Issue:7

    An autopsy case of hemolytic uremic syndrome after treatment with antineoplastic agents for advanced gastric carcinoma is reported. A 70 year-old woman underwent partial gastrectomy for gastric carcinoma on April 16, 1987 (P0H0S2N4, Stage IV). She was treated with Mitomycin C (MMC), UFT, OK-432 and PSK as post operative chemotherapy. Total doses were 60 mg of MMC, 33.9 g of UFT, 55 KE of OK-432 and (507 g) of PSK. She suffered from occult blood in urine in September 1987, thrombocytopenia and anemia in October, edema and hypertension in November and died due to acute renal failure and pulmonary failure on December 5, 1987. It seemed that the cause of death was hemolytic uremic syndrome induced by antineoplastic agents.

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Mitomycin; Mitomycins; Picibanil; Proteoglycans; Stomach Neoplasms; Tegafur; Uracil

1990